ADVANCED THERAPIES
Advanced Fluid Management for ATMPs
By providing modular standards and highly customizable solutions, we support you in writing a new chapter in advanced therapy medicinal products (ATMPs): Our single-use technologies and sterile consumables come with the flexibility required for fast turnaround times in advanced therapeutic approches for the areas of controlled freezing & thawing, product aliquotation & filtration and all required logistic steps.
Advanced Fluid Management for Cell and Gene Therapies
Cell Therapies
Fluid Management Solutions around Single-Use Technologies for Cell Therapies Applications | Autologous Cell Therapy | Allogeneic Cell Therapy
Gene Therapies
Fluid Management Solutions around Single-Use Technologies for Gene Therapies |Primary Packaging | Fill & Drain | Freeze & Thaw | Transport | Gene therapy solutions
Gene-Modified Cell Therapy
Gene-modified Cell Therapies enable unique approaches to novel treatments, including CAR-T therapies. After collection of cells from patients the genes are edited ex vivo to boost their function and persistence before they are re-administered into the patients body.
Advanced Fluid Management for Viral Vectors & Plasmid DNA (pDNA)
Viral Vectors
With the discovery of new fields of application for viral vectors in gene therapy comes an increased need for dedicated solutions along their supply chain
Plasmid DNA (pDNA)
Plasmid DNA (pDNA) is used as a starting material for the production of mRNA, most commonly known in the context of COVID-19 vaccines. In addition, pDNA is used at the staring point of producing viral vectors, such as AAVs (Adeno-Associated Virus Vectors) and Lentiviral Vectors.